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Background:Aging is a complex process that involves the interplay of genetic, epigenetic,
and environmental factors. Identifying aging-related biomarkers holds great potential for
improving our understanding of complex physiological changes, thereby providing a means
to investigate the mechanism by which aging inﬂuences various diseases. Method and
Results: We performed a parallel study of microRNA and gene expression proﬁling of
peripheral blood in a group of healthy young adult women, among which 13 were aged
22–25 and 9 were aged 36–39 years old. We identiﬁed a signiﬁcantly distinct pattern of
microRNA, but not gene expression proﬁling, between these two young adult women
groups. We also performed correlation analysis of expression levels between all pairs of
age-associated microRNAs and genes and identiﬁed a weak global correlation between
these two types of expression levels. A signiﬁcant involvement of estrogen regulation was
observed by pathway analysis of themost differentially expressedmicroRNAs that included
miR-155, -18a, -142, -340, -363, -195, and -24. Conclusion: Our results suggest that the
change in global microRNA expression in the peripheral blood is associated with normal
aging in young adult women. This change may precede global gene expression changes.
Future studies are needed to investigate the regulatory mechanism of the estrogen-related
microRNAs and associated diseases.
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INTRODUCTION
Aging is a complex process that involves the interplay of genetic,
epigenetic, and environmental factors. Human physiological func-
tions normally decline with age and aging is a major risk factor
for several chronic diseases and conditions such as obesity, cardio-
vascular disease, dementia, osteoporosis, type two diabetes, and
cancer. Identifying aging-related biomarkers holds great poten-
tial for improving our understanding of complex physiological
changes, thereby providing a means to investigate the mechanism
by which aging inﬂuences various diseases.
High throughput technologies such as microarrays are use-
ful tools for the systematic examination of complex molecular
processes. The gene expression proﬁles of several model organ-
isms have been used to investigate the aging process (McCarroll
et al., 2004; Fabrizio et al., 2005). Animal studies also use these
technologies to investigate tissue-speciﬁc changes of gene expres-
sion during normal aging or through experimental conditions
such as caloric restriction to understand the transcriptional regu-
lation of aging (Lee et al., 1999, 2000; Tollet-Egnell et al., 2001).
Recently, a new class of molecules, namely microRNAs (miRNAs),
has been recognized as master post-transcriptional regulators of
mRNAs (Sun et al., 2010). MiRNAs are a class of small (20–25
nucleotides) non-coding RNAs that are involved in several bio-
logical and pathological processes including cell differentiation,
proliferation, and apoptosis (Bartel, 2004). Through imperfect
pairing with target protein coding genes, miRNAs may lead to
translational repression or cleavage of the target protein coding
genes. More than 30% of the entire genome is predicted to be tar-
gets of miRNAs (Filipowicz et al., 2008). Dysregulation of miRNAs
has been found in malignant tumors and changes in circulating
miRNAs have been linked to coronary artery disease (Garzon et al.,
2009; Lee and Dutta, 2009; Fichtlscherer et al., 2010). Similarly,
miRNAs were found to be involved with aging. Somel et al. (2010)
studied the link between development and aging in human and
macaque brain and found that the majority of miRNA and gene
expression changes that occur during the aging process are in fact
reversal patterns of development, suggesting a direct link between
development regulation and expression changes associated with
aging. The authors also demonstrated that in both species,miRNA
expression is highly inﬂuenced by age.
Recently, Hooten et al. (2010) identiﬁed several miRNAs dif-
ferentially expressed between young (30 years of age) and old
(64 years of age) adults and showed an overall decline in miRNA
expression in older adults compared to younger adults. However,
it is unknown whether changes in miRNA levels are related to
the normal aging process during young adulthood. Here, we per-
formed a parallel comparison of miRNA and mRNA proﬁling
patterns between 13 healthywomen aged 22–25 and 9women aged
36–39 years old. Our study identiﬁed a speciﬁc miRNA signature
that is involved in estrogen regulation and was differentially
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expressed between these two age groups of young adult
women.
MATERIALS AND METHODS
STUDY PARTICIPANTS
Twenty-two healthy young adult women without diabetes or
inﬂammatory diseases took part in this study. Among these 22
women, 13 were 22–25 years old (mean± SD: 23.6± 0.8) and 9
were 36–39 years old (37.2± 1.1). The younger age group included
nine white and four Asian women, while the older age group
included one Hispanic, three Asian, and ﬁve white women. Each
volunteer participant had 5ml fasting whole blood drawn into two
PAXgene tubes (QIAGEN Inc., Valencia, CA, USA) for total RNA
isolation. The Institutional Review Board at NorthwesternUniver-
sity approved the study and all participants gave written informed
consent.
TOTAL RNA EXTRACTION AND mRNA AND MIRNA PROFILING
Whole blood (5ml) from each participant was drawn into two
PAXgene tubes and was incubated at room temperature for 3 h
before being frozen at −70˚C. Total RNA was extracted from the
ﬁrst PAXgene blood tube using the PAXgene blood RNA extrac-
tion kit according to the manufacturer’s protocol. MiRNA was
extracted from the second PAXgene blood tube using TRIZOL
(Invitrogen) as per the manufacturer’s protocol. The amount of
microRNA in each sample was evaluated by the small RNA chip
using the 2100 Agilent Bioanalyzer. The concentration and the
quality of the extracted total RNA were accessed by NanoDrop
(Thermo Fisher Scientiﬁc Inc., Waltham, MA, USA) and Bioan-
alyzer 2100 (Agilent technologies Inc., Santa Clara, CA, USA),
respectively. Total RNA preparations with a 260/280 ratio between
1.98–2.22 and an RNA integrity number (RIN) number >7.5 with
sufﬁcient quantity were used for the mRNA expression analysis.
Globin reduction was performed using the Ambion GLOBINclear
kit (Ambion Inc., Austin, TX, USA). The quality of the globin-
reduced RNA samples was assessed by the Bioanalyzer 2100. High
quality samples were used to make ﬁrst and second strand DNA
followed by an IVT reaction. The size distribution of the result-
ing biotin-labeled cRNA and the yield was checked by Agilent
2100 andNanoDrop, respectively.A normalized amount of labeled
cRNA was hybridized to the Human Ref-8 beadchips (Illumina,
San Diego) for 18 h at 55˚C. After washing and staining with Cy3,
the chips were scanned on the Illumina iScan. The Ref-8 BeadChip
allows genome-wide expressionproﬁling ofmore than 22,000 gene
transcripts and known alternative splice variants from the RefSeq
database. For miRNA proﬁling, we used the Illumina 96-sample
UniversalMatrixArray,which assesses>500miRNAs described in
the Sanger Institute miRBase database and putative miRNAs from
the literature resulting in a total of 739 miRNAs. We followed the
manufacturer’s protocol. All 22 miRNA samples were run on a
single Illumina miRNA plate. The microarray analysis was per-
formed at the Northwestern Genomic Core Facility at the Center
for Genetic Medicine. The full mRNA and miRNA microarray
data were submitted to the NCBI Gene Expression Omnibus data1
under accession number GSE30205.
1http://www.ncbi.nlm.nih.gov/geo/
QUANTITATIVE RT-PCR
Expression levels of four differentially expressed miRNAs (Let-7c,
miR-425, miR-199b, and miR-142-5p) were validated by quan-
titative real time RT-PCR using the TaqMan MicroRNA Assay
(Applied BioSystems, Foster City, CA,USA) according to theman-
ufacture’s protocol. RNU44 was used as the endogenous control
to normalize the data. Relative expression levels of these miRNAs
were determined by the -CT method. All experiments were
performed in triplicate.
DATA ANALYSIS
Illumina BeadStudio software (Illumina, Inc., SanDiego)was used
to translate the scanned images into expression data, which were
further log-transformed and normalized by the quantile normal-
ization procedure using the Bioconductor package: affy. Princi-
pal component analysis (PCA) was used to identify grouping of
mRNA and miRNA proﬁles among all 22 women. Percentages of
total data variance for principal components 1 and 2 were cal-
culated for both microarray data sets. Hierarchical clustering2
was used to identify the miRNA expression pattern in the clus-
ter members. Signiﬁcance analysis of microarrays (Tusher et al.,
2001; SAM) was used to identify differentially expressed miRNAs
between younger and older women. Standardized fold changes
were calculated as mean expression differences divided by pooled
SD in the log scale. For miRNAs that were differentially expressed
between younger and older women (34 miRNAs), Pearson cor-
relation coefﬁcients were calculated for each of these individual
miRNAs and all 22,184 mRNAs. For each miRNA, SAM was used
to identify signiﬁcantly correlative mRNAs (false discovery rate,
FDR< 20%). Ingenuity pathway analysis (IPA)3 was used to iden-
tify enriched pathways or biological functions among differentially
expressed miRNAs.
RESULTS
GLOBAL miRNA BUT NOT mRNA PROFILING IS DISTINCT BETWEEN
YOUNGER AND OLDER WOMEN
Principal component analysis showed a distinct pattern of miRNA
expression proﬁling between the two age groups of women. Specif-
ically, all 13 younger women except one clustered on the left while
the nine samples from older women were spread out on the right
(Figure 1A). Of note, the cluster for the younger women was
much more compact than for the older women, suggesting that
miRNA proﬁles are more similar among younger women than
among older women. In contrast, the mRNA expression proﬁles
were mixed between the older and younger women groups and
no distinct pattern was observed (Figure 1B). We observed three
miRNA proﬁles from older women on the furthest right of the
PCA plot that did not correspond with the three mRNA proﬁles
of older women on the lower part of the PCA plot. In addition,
the miRNA proﬁle of one younger woman deviated from all of the
other younger women and did not correspond with the mRNA
proﬁle of younger women on the right-lower corner of the PCA
plot. The miRNA proﬁle of this younger woman can be seen at the
third column from the right in the clustering heatmap (Figure 1C).
2http://rana.lbl.gov/EisenSoftware.htm
3www.ingenuity.com
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FIGURE 1 | Parallel comparison of miRNA and mRNA profiling patterns
among 9 older (aged 36–39) and 13 younger (aged 22–25) adult women
by principal component analysis. (A) miRNA proﬁling; (B) mRNA proﬁling.
For the miRNA data, the ﬁrst principal component (X -axis) explains 40.8% of
total variation and the second principal component explains (Y -axis) 14.5% of
total variation. For the mRNA data, the ﬁrst and second principal components
explain 18.4 and 13% of total variation, respectively. (C) Cluster analysis of
miRNA proﬁling.
DIFFERENTIALLY EXPRESSED miRNAS BETWEEN YOUNGER AND
OLDER WOMEN
Based on two-sample t tests, a total number of 148 miRNAs
(20% of 739 miRNAs represented in the array) have a nominal
p-value< 0.05 in the older women versus younger women com-
parison,which ismore than expected by chance alone (Figure 2A).
In contrast, only 6.7% of mRNA transcripts (Figure 2B) showed
differential expression between the two age groups at the nomi-
nal p-value 0.05 level. SAM identiﬁed 34 differentially expressed
miRNAs between older and younger women with a FDR of 0.1%
(Table 1), while only ﬁve genes had an FDR of 0.1%. Consistent
with PCA, this result indicates a signiﬁcantly different miRNA,
but not mRNA, expression pattern between the two age groups.
The expression of four miRNAs with FC≥ 1.5 or FC≤−1.5,
two upregulated in older women (let-7c and miR-425) and two
downregulated in olderwomen (miR-199b andmiR-142-5p),were
validated by quantitative real time RT-PCR (Figure 3).
NETWORK ANALYSIS OF DIFFERENTIALLY EXPRESSED miRNAs
To investigate potential regulatory networks among differentially
expressed miRNAs, we used IPA software to analyze the func-
tional enrichment of the 34 miRNAs with an FDR of 0.1%. IPA
showed that the top biological functions (P = 2·10−9∼5·10−4)
represented by this list of differentially expressed miRNAs were:
(1) reproductive system disease with six molecules (miR-142, 195,
155, 425, 340, and let-7c), (2) cancer with seven molecules (miR-
142, 155, 195, 340, 425, let-7c, and let-7e), and (3) skeletal and
muscle disorder with four molecules (miR-155, 195, let-7c, and
let-7e). Seven of the 34 differentially expressedmiRNAs (miR-340,
363, 18a, 142, 155, 195, and 24) are interconnected in a net-
work involving hormone regulation through the estrogen receptor
(ESR1) and/or β-estradiol (Figure 4).We examined the expression
correlation between pairs of miRNA–mRNA shown in Figure 4
and found that two pairs of miRNA–mRNA, mi-340/EFNB2 and
mi-155/EGFR, showed pronounced negative correlations (Pearson
correlation: −0.45 and −0.31; p-value: 0.037 and 0.16, respec-
tively). Using the microarray gene expression data, we deter-
mined that the mRNA levels of EGFR (p = 0.05), but not EFNB2
(p = 0.57),were signiﬁcantly different between the two age groups.
THE CORRELATION BETWEEN PAIR-WISE mRNA/miRNA LEVELS IS
WEAK
We evaluated the signiﬁcance levels of all pair-wise correlations
between allmRNAs and the 34 age-associatedmiRNAs using SAM,
a non-parametric permutation test. For each of these 34 individ-
ual miRNAs, we identiﬁed very few signiﬁcant correlative mRNAs
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FIGURE 2 | Distributions of p-values from t tests comparing younger and
older women. (A) miRNA proﬁling; (B) mRNA proﬁling. The width of each bin
represents an interval of 0.05 p-value. The horizontal dashed lines indicate the
expected distribution under the null hypothesis of no differential expression. If
there were no differential expression observed, all the bars will be
approximately at the height of the dashed line.
at an FDR of 20% except for miR-563 (see Table 1). This is even
more evident for the 20miRNAs that were downregulated in older
women. The miRDB miRNA database (Wang, 2008) identiﬁed 64
genes as predicted targets of miR-563. However, only one of the
72 genes that correlated with miR-563 was found to be a predicted
target. The ﬁndings that only a few signiﬁcant correlative mRNA–
miRNA pairs were identiﬁed and very few correlative genes were
predicted targets suggest that the regulation of the differentially
expressedmiRNA is likely to occur at the post-transcriptional level,
but not at the mRNA level.
DISCUSSION
Our results suggest that miRNA, but not mRNA, proﬁles are asso-
ciated with normal aging. This may be explained by the fact that
there are several mechanisms that underlie gene expression regu-
lation in addition to negative modulation by miRNAs. Every step
in the process is subject to dynamic regulation in the cell including
structural changes in the chromatin to make a gene open for tran-
scription, transcription of DNA into RNA, splicing of RNA into
mRNA, editing, and further covalent modiﬁcations of the mRNA
(Black, 2003; Saha et al., 2006; Shabalina et al., 2006). Therefore,
there are mechanisms that together “compensate” for the initial
dysregulation of miRNAs and, only later in the process of aging,
these mechanisms will become insufﬁcient for the tight control of
gene expression, which ultimately leads to the occurrence of the
altered phenotype (Issa, 2004).
Our network analysis of the most differentially expressed miR-
NAs revealed a signiﬁcant involvement of estrogen regulation,
which is an important implication because estrogen is one of the
most crucial hormones and has a wide effect on human disease
and physiological processes (Moggs and Orphanides, 2001; Deroo
and Korach, 2006). As women age, changes in estrogen levels are
often associatedwith several chronic diseases such as breast cancer,
osteoporosis, and atherosclerosis. SeveralmiRNAs in this estrogen-
associatednetworkhave been linked to these diseases. For example,
miR-155 is upregulated in the older age group and this miRNA
regulates EGFR (Figure 4). Interestingly, EGFR is regulated by β-
estradiol and is involved in the pathophysiology of several types
of cancer, and was downregulated at the mRNA level in the older
age group. Moreover, miR-155 inhibited the tumor suppressor
gene, SOCS1, in a breast cancer cell line and was associated with
estrogen/progesterone receptor levels in women with breast can-
cer (Iorio et al., 2005; Zhu et al., 2009; Jiang et al., 2010). MiR-155
also targets transcripts coding for proteins involved in LPS/TNF-α
signaling, which is crucial in the innate immune and inﬂamma-
tory response (Tili et al., 2007). MiR-18a is downregulated in the
older age group, and thismiRNA regulates ESR1,which is also neg-
atively regulated by β-estradiol. MiR-18a prevents translation of
estrogen receptor-α and promotes the development of hepatocel-
lular carcinoma inwomen (Liu et al., 2009).MiR-195 (upregulated
in older age) and miR-24 (downregulated in older age) both reg-
ulate MAPK14, which negatively regulates EGFR (Figure 4). Both
reportedly function as modulators of cardiac hypertrophy and
heart failure (van Rooij et al., 2006). MiR-142 regulates EGR1,
which is involved in atherosclerosis and is also negatively regu-
lated by beta-estradiol (Patino et al., 2006). Finally, miR-340 and
miR-363 (both downregulated in the older age group) regulate
EFNB2, which is involved in several types of cancer and is also neg-
atively regulated by beta-estradiol (Pedram et al., 2002). Thus, this
network represents a synergistic control of multiple molecules in
estrogen regulation. Given that miRNA changes in midlife might
underlie some of the early pre-clinical changes that ultimately
manifest as age-associated decline, (Wang, 2007) age-related miR-
NAs, individually or in combination, may be used as diagnostics
for scoring “physiological” age to predict an individual’s risk for
chronic diseases.
We sought to identify miRNAs and their target genes using
correlation analysis by parallel comparison between miRNA and
mRNA expression proﬁling. Our result suggests that relatively few
pairs of miRNAs and mRNAs are signiﬁcantly correlated, which is
not surprising. First, each miRNA can potentially target hundreds
of mRNAs and most mRNA 3′ UTRs contain potential binding
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Table 1 | Thirty-four differentially expressed microRNAs at an FDR of
0.1% between younger and older women.
MicroRNA Fold
change
Illumina probe sequence No. of
correlative
genes*
MicroRNAs expressed higher in older women
hsa-let-7c‡ 1.4 TACACAGCGACCGTACCATCGT 6
hsa-miR-195 1.37 AGGTCGCTATCCAACTCGGATC 0
hsa-miR-563 1.62 CGAGCGGCAGTTAGTCATGTCG 72
hsa-miR-572 1.11 CTCAGAGGGTCGCTGCATAAGC 16
hsa-miR-425 2.01 CGGCGGAAGGTAGATCGTCCTC 2
hsa-miR-155 1.11 TCCAGATAGCGAGCAGTTACGG 15
hsa-miR-614 1.19 CGCTGTGCCGAAGAGAGTATCC 0
hsa-miR-369-5p 1.21 TCGGCTATTGAGTCCGCGCAAT 16
hsa-miR-551a 1.18 GGATAGTGCTGCCCGAAGCGTA 2
hsa-miR-138 1.12 AATAGACCGAGTCGATGTGGCG 1
hsa-miR-518a 1.31 GACGGAGCGGTATTACCATGCG 14
hsa-miR-548a 1.18 CTTCGTAAGTGAGGCCGGTTCA 0
hsa-miR-520g 1.15 CTAATTGACGCGGCTGAAGCTG 1
hsa-let-7e 1.33 GATCGAGTCGCCCGTGCTATCA 0
MicroRNAs expressed lower in older women
hsa-miR-18a‡ 1.27 TACAGCGTTCGAGCCCTTAGTC 1
hsa-miR-378 1.49 CTAGAACTCGGAAGGTTGCGAC 1
hsa-miR-338 1.63 ATGGGCGAGCTACCTGACGTAT 0
hsa-miR-128a‡ 1.33 TAGCGAAAGGTTCGGCACTCGA 0
hsa-miR-616 1.38 CCTGCGGATAGGAAGGTTCGAC 2
hsa-miR-199b 1.53 ACATCGCCGGTATGCCTCTACG 0
hsa-miR-340 1.46 AGAAGGCGTCCGTCTTTGAGGC 0
hsa-miR-193a 1.4 CCCTTTCGGACTGACAACCGGG 6
hsa-miR-328 1.4 TCGCCATGTCGCATGATACAGC 3
hsa-miR-363 1.35 CTAGGCAAGGGCGTCTTACCGT 1
hsa-miR-142-5p 1.81 TCGCCGAACATACGGGTTCTAG 0
hsa-miR-565 1.64 GCCCAGTTAAGCTGCGCGAATG 0
hsa-miR-454-5p 1.31 ATCACGTCGAATGGTGGGGTCT 0
hsa-miR-24‡ 1.28 TCGCTACCGCACCGTCTGAAAG 2
hsa-miR-331 1.14 GTCATCCCGCATTGGTCAACGG 3
hsa-miR-574 1.39 TCTGGGAGTACCTAGCTTCGGA 0
hsa-miR-624 1.27 CGGGCAGATTACGCTCTAGTGA 0
hsa-miR-28 1.36 ACGAGGCTTGCGTAGGAACAGT 0
hsa-miR-548d 1.32 GGATGCGTTATGAACCACCCGT 2
hsa-miR-618‡ 1.27 TCGATACCGCAAGGTCATTGGC 0
*Correlated with a miRNA at a false discovery rate of 20% from signiﬁcance
analysis of microarrays.
‡Consistent with the fold change direction in Hooten’s age-associated miRNA list.
sites for a large number of individual miRNAs. Furthermore, the
targets of many miRNAs can modulate the expression of other
miRNAs, resulting in complex feedback loops. Therefore, inter-
actions between miRNAs and mRNAs may not be explained by
simple correlation structure. Finally, the predominant mechanism
of regulation by miRNAs in mammals appears to be translational
inhibition, suggesting that a correlation betweenmiRNA and pro-
tein levels would bemore likely than a correlation betweenmiRNA
and mRNA levels. Although other studies have attempted to use
FIGURE 3 | Quantitative RT-PCR validation of four age-associated
miRNAs identified from the microarray experiment. Bars represent fold
changes comparing expression between older and younger women. A
positive (negative) fold change represents up (down)-regulation of
expression in older women.
FIGURE 4 | An estrogen regulation network of age-associated
differentially expressed miRNAs from Ingenuity Pathway Analysis.
Dashed arrow: negative regulation; solid arrow: positive regulation.
β-estradiol represents protein.
correlation structure and/or predicted miRNA binding sites to
identify miRNA targets, (Wang and Li, 2009; Nunez-Iglesias et al.,
2010; Enerly et al., 2011) such approaches are not fruitful in our
data and may lead to a large number of false positives.
It has been demonstrated that when there is a large age range
between study participants (∼30 years), older individuals show
a relative decrease of miRNA expression overall compared to
younger participants (Hooten et al., 2010). However, although we
did not observe this global pattern in our study in which the age
difference was approximately 10 years between study participants,
we did observe differential expression of speciﬁcmiRNAs between
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the two groups of young adult women (Table 1). In summary, our
results suggest that prior to an overall dysregulation of mRNA
expression with aging, there are ﬂuctuations in the expression of
speciﬁcmiRNAs thatmay be related to age-speciﬁc changes. Inter-
estingly, these speciﬁc aging-related miRNAs seem to be involved
in estrogen-regulated processes in women. Our cross-sectional
study could not address the casual relation between estrogen and
the age-associated miRNAs. Further study is needed to investi-
gate the regulatory mechanisms among these estrogen-associated
miRNAs.
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